MedTrace Logo

Actis Total Hip System 2 Year Follow-up

NCT02783274 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2025-08-15

Study results available
· View outcomes & findings →

Summary

Two-year (2 year) information regarding the performance of the commercially available Actis™ Total Hip System in order to obtain and evaluate the clinical outcomes on a series of cementless primary total hip arthroplasty (THA) and hemi-hip arthroplasty procedures using clinical, radiographic and device and procedure related adverse event assessments.

Conditions

  • Osteoarthritis
  • Traumatic Arthritis
  • Rheumatoid Arthritis
  • Congenital Hip Dysplasia
  • Avascular Necrosis of the Femoral Head
  • Acute Traumatic Fracture of the Femoral Head or Neck
  • Certain Cases of Ankylosis
  • Non-union of Femoral Neck Fractures
  • Certain High Sub-Capital & Femoral Neck Fractures in Elderly

Interventions

DEVICE

Actis Total Hip System

Total Hip Replacement and Hemi-hip Replacement

Sponsors & Collaborators

  • DePuy Orthopaedics

    lead INDUSTRY

Principal Investigators

  • Deborah German, BS · DePuy Synthes

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2024-03-13
Completion
2024-03-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02783274 on ClinicalTrials.gov